Polartechnics moves into Pakistan
Monday, 09 March, 2009
Sydney’s Polartechnics has received another international order for its TruScreen cervical cancer screening technology, this time with Pakistan.
The Pakistani Government has initially ordered 100 units but expects to order more in the future.
TruScreen is a point of care detection device for cervical cancer. Cervical cancer is the fourth most common cancer in Pakistan, which has a female population of more than 85 million.
Last month, Polartechnics signed distribution agreements with major medical companies in Indonesia, Thailand, the Philippines and Sri Lanka.
Polartechnics also produces a self-administered HPV test called CerviScreen under a joint venture with Genera BioSystems and Gribbles Pathology.
Antimicrobial resistance in children rises globally — 100K+ samples reveal
Spanning 82 countries, there was an increase in every region between 2004 and 2022, with the...
Robotic laboratory to fast-track drug invention, trials and commercialisation
The lab will house an automated system for high-throughput X-ray crystallography, often referred...
Bio-inspired robotic bird has stable flight in its sights
The nankeen kestrel is among the most stable fliers in the avian world. Using motion capture...
